Skip to main content

Home/ Health Now/ Group items tagged anti-influenza

Rss Feed Group items tagged

Matti Narkia

Crucell's Revolutionary Antibody for Universal Therapy Against Flu - 0 views

  •  
    Leiden, The Netherlands (February 26, 2009) - Dutch biopharmaceutical company Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) announces that the journal Science today published a study showing why Crucell's novel anti-influenza antibody is so effective against such a broad range of influenza virus subtypes. These characteristics make the Crucell antibody CR6261 a potentially revolutionary therapy against seasonal and pandemic flu.
1 - 1 of 1
Showing 20 items per page